Estimates of Hepatitis C Seroprevalence and Viremia in State Prison Populations in the United States.

Background: Prior studies demonstrate that eliminating hepatitis C virus (HCV) in the United States (US) heavily depends on treating incarcerated persons. Knowing the scope of the carceral HCV epidemic by state will help guide national elimination efforts.

Methods: Between 2019 and 2023, all state prison systems received surveys requesting data on hepatitis C antibody and viremic prevalence.